Healthy subjects
Conditions
Interventions
16-week intake of the test food
16-week intake of the placebo food
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Japanese males and females aged 20 to 69 years old or younger at the time of obtaining informed consent 2)Patients who have a BMI 25 kilogram/m2 or less 3) Subjects with uncorrected or corrected visual acuity of 0.7 or higher for both eyes 4)Persons who have not undergone LASIK surgery(myopia correction surgery) 5)Persons who are regularly aware of eye fatigue 6)Those who can stop eye drops for astigmatism improvement during the test period 7)Persons who can be contacted by personal computers or smartphones 8)Those who were fully informed of the purpose and content of the study, were able to give consent, voluntarily volunteered to participate in the study, and agreed to participate in the study in writing.
Exclusion criteria
Exclusion criteria: 1)Patients who are currently receiving any medication or outpatient treatment 2)Subjects currently undergoing exercise or diet therapy under the supervision of a physician. 3)Persons who are likely to develop allergies from test foods 4)People with pollinosis 5)Patients with current or past history of drug dependence or alcohol dependence 6)Patients who have been attending the hospital with psychiatric disorders (depression, etc.) or sleep disorders, or who have a history of psychiatric disorders in the past 7)Night or shift workers 8)Person who is extremely irregular in lifestyle such as eating and sleeping 9)Persons engaging in extreme prey 10)Patients with a current or past history of serious diseases such as diabetes mellitus, liver disease (hepatitis), renal disease, heart disease, etc., thyroid disease, adrenal disease, or other metabolic diseases. 11)Patients with ocular diseases other than refractive errors (hyperopia, myopia, astigmatism) 12)Persons with eyelashes extension 13)Persons who use health foods, supplements, and drugs that affect eye function. 14)Those who participated in another clinical study (study) within 3 months after the date of informed consent, or who are planned to participate in another clinical study (study) during the study period. 15)A blood sample exceeding 200 ml within 3 months or 400 ml within 3 months after the date of obtaining informed consent or a component blood donation. 16)Subjects who are currently pregnant or breast-feeding, or who may be pregnant or breastfeeding during the study period. 17)Current smokers or those who smoked within the past year 18)Persons who have difficulty complying with the records of various surveys 19)Subjects who are determined to be ineligible based on laboratory values and measurements at the time of SCR. 20)Other persons for whom the principal investigator judges to be inappropriate as subjects of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Macular pigment optical density | — |
Secondary
| Measure | Time frame |
|---|---|
| Accommodative power | — |
Countries
Japan
Contacts
Public ContactDaisuke Ochitani
HUMA R&D CORP Clinical Development Division
Outcome results
None listed